Ligand validation:5VVB

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VVB_BTB_A_504	77%	77%	0.13	0.97	0.36	0.55	-	-	2	0	100%	1
5VVB_BTB_B_506	74%	74%	0.083	0.911	0.45	0.56	-	-	2	0	100%	1
5VVB_BTB_D_504	72%	69%	0.108	0.932	0.41	0.76	-	-	1	0	100%	1
5VVB_BTB_B_504	66%	63%	0.107	0.911	0.4	0.99	-	1	1	0	100%	1
5VVB_BTB_C_504	51%	74%	0.17	0.923	0.4	0.59	-	-	0	0	100%	1
5VVB_BTB_A_505	46%	47%	0.184	0.919	0.66	1.36	-	-	1	0	100%	1
5VVB_BTB_B_505	38%	80%	0.167	0.868	0.37	0.47	-	-	1	0	100%	1
5VVB_BTB_C_505	38%	67%	0.156	0.855	0.36	0.9	-	-	0	0	100%	1
5VVB_BTB_D_505	28%	68%	0.232	0.886	0.49	0.72	-	-	3	0	100%	1
6PP3_BTB_B_509	82%	66%	0.115	0.972	0.36	0.94	-	1	1	0	100%	1
7TSH_BTB_C_504	82%	67%	0.124	0.981	0.5	0.75	-	-	0	0	100%	1
6NH8_BTB_C_504	82%	76%	0.113	0.967	0.38	0.57	-	-	2	0	100%	1
7TSL_BTB_A_504	77%	60%	0.115	0.954	0.41	1.1	-	-	2	0	100%	1
5UOC_BTB_D_504	75%	46%	0.122	0.954	0.59	1.47	-	1	2	0	100%	1
5O5D_BTB_B_504	100%	66%	0.02	0.995	0.94	0.38	2	-	0	0	100%	1
5O59_BTB_A_605	99%	76%	0.057	0.987	0.52	0.44	-	-	2	0	100%	1
2OB3_BTB_A_906	98%	13%	0.06	0.986	2.82	1.16	4	1	0	0	100%	1
9FZ6_BTB_C_902	98%	69%	0.07	0.989	0.83	0.37	-	-	1	0	100%	0.2
2OQL_BTB_B_701	95%	63%	0.066	0.969	0.66	0.75	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.